VCYT logo

Veracyte, Inc. (VCYT)

Profile

Full Name

Veracyte, Inc.

Ticker

NASDAQ: VCYT

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

October 30, 2013

Indexes

Not included

Website

https://www.veracyte.com

Employees

824

Key Details

Price

$30.82(-3.66%)

Market cap

$2.42B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$445.76M(+23.46% YoY)

Annual EPS

$0.31(+130.39% YoY)

PE ratio

93.39

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $30.82
    VCYT price is $30.82

    30-Day Relative Volume

    0.72
    VCYT 30-day relative volume is 0.72

    Price Performance

    Price Most recent change

    -3.66%
    VCYT price was down -3.66% on Sep 10, 2025

    Price YTD change

    -22.17%
    VCYT price is down -22.17% since January 1st

    Price 1-year change

    +3.63%
    VCYT price is up +3.63% year-on-year

    Price 3-year change

    +54.49%
    VCYT price is up +54.49% over the past 3 years

    Price Range

    Price All-time high

    $86.03
    VCYT price is currently -64.18% below its historical high of $86.03

    Price 3-year low

    $14.92
    VCYT price is currently +106.57% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.42B
    VCYT market capitalization is $2.42 billion

    Market cap 3-year change

    +69.8%
    VCYT market capitalization is up +69.8% over the past 3 years

    Market cap All-time high

    $5.43B
    VCYT market capitalization is currently -55.36% below its historical high of $5.43 billion

    Market cap sector rank

    82.77%
    VCYT market capitalization is higher than 82.77% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.42%
    VCYT shares outstanding is up +2.42% year-on-year

    Shares Outstanding 3-Year Change

    +9.91%
    VCYT shares outstanding is up +9.91% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.24
    VCYT beta is 1.24

    200-day SMA

    $33.14
    VCYT price is currently -7.01% below its 200-day simple moving average

    50-day SMA

    $27.50
    VCYT price is currently +12.07% above its 50-day simple moving average

    RSI

    56.97
    VCYT 14-day relative strength index is 56.97

    Volume

    0.72
    VCYT 30-day relative volume is 0.72

    ATR

    $1.20
    VCYT average true range is $1.20

    10-day Historical Volatility

    40.39%
    VCYT 10-day historical volatility is 40.39%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $445.76M
    VCYT annual revenue is $445.76 million

    Revenue Analysts estimate

    $500.29M
    VCYT annual revenue is currently -10.90% lower than the consensus analysts' forecast

    Revenue 1-year change

    +23.46%
    VCYT annual revenue is up +23.46% year-on-year

    Revenue Sector rank

    80.35%
    VCYT annual revenue is higher than 80.35% of companies in Healthcare sector

    EPS

    EPS

    $0.31
    VCYT annual earnings per share is $0.31

    EPS Analysts estimate

    $1.43
    VCYT annual earnings per share is currently -78.26% lower than the consensus analysts' forecast

    EPS 1-year change

    +130.39%
    VCYT annual earnings per share is up +130.39% year-on-year

    EPS Sector rank

    86.04%
    VCYT annual earnings per share is higher than 86.04% of companies in Healthcare sector

    Profit

    Gross profit

    $298.14M
    VCYT annual gross profit is $298.14 million

    Gross margin

    66.88%
    VCYT annual gross profit margin is 66.88%

    Operating profit

    $19.51M
    VCYT annual operating income is $19.51 million

    Operating margin

    4.38%
    VCYT annual operating profit margin is 4.38%

    Net income

    $24.14M
    VCYT annual net profit is $24.14 million

    Net margin

    5.42%
    VCYT annual net profit margin is 5.42%

    Expenses

    Total expenses

    $426.25M
    VCYT annual total expenses is $426.25 million

    Operating expenses

    $278.63M
    VCYT annual total operating expenses is $278.63 million

    Cost of goods sold

    $147.62M
    VCYT annual cost of goods sold is $147.62 million

    Selling, general & administrative expenses

    $206.04M
    VCYT annual SGA is $206.04 million

    Depreciation and amortization

    $23.46M
    VCYT annual depreciation & amortization is $23.46 million

    Interest expense

    $2000.00
    VCYT annual interest expense is $2000.00

    Income tax

    $1.61M
    VCYT annual income tax is $1.61 million

    EBIT & EBITDA

    EBIT

    $19.51M
    VCYT annual earnings before interest & taxes is $19.51 million

    EBITDA

    $42.97M
    VCYT annual EBITDA is $42.97 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.33B
    VCYT annual total assets is $1.33 billion

    Non current assets

    $927.77M
    VCYT annual long term assets is $927.77 million

    Current assets

    $372.27M
    VCYT annual total current assets is $372.27 million

    Cash and cash equivalents

    $239.09M
    VCYT annual cash & cash equivalents is $239.09 million

    Accounts receivable

    $46.52M
    VCYT annual accounts receivable is $46.52 million

    Inventory

    $21.75M
    VCYT annual inventory is $21.75 million

    Liabilities

    Total liabilities

    $158.05M
    VCYT annual total liabilities is $158.05 million

    Long term liabilities

    $45.44M
    VCYT annual total long term liabilities is $45.44 million

    Current liabilities

    $78.63M
    VCYT annual total current liabilities is $78.63 million

    Accounts payable

    $8.63M
    VCYT annual accounts payable is $8.63 million

    Debt

    Total debt

    $50.74M
    VCYT annual total debt is $50.74 million

    Total debt 1-year change

    +301.72%
    VCYT annual total debt is up +301.72% year-on-year

    Long term debt

    $43.24M
    VCYT annual long term debt is $43.24 million

    Short term debt

    $7.50M
    VCYT annual short term debt is $7.50 million

    Equity & Capital

    Shareholders equity

    $1.18B
    VCYT annual stockholders equity is $1.18 billion

    Book value

    $1.18B
    VCYT annual book value is $1.18 billion

    Retained earnings

    -$443.98M
    VCYT annual retained earnings is -$443.98 million

    Working capital

    $293.63M
    VCYT annual working capital is $293.63 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $75.10M
    VCYT annual cash flow from operations is $75.10 million

    Cash from operations 1-year change

    +69.82%
    VCYT annual cash flow from operations is up +69.82% year-on-year

    Cash from investing

    -$56.27M
    VCYT annual cash flow from investing activities is -$56.27 million

    Cash from investing 1-year change

    -472.39%
    VCYT annual cash flow from investing activities is down -472.39% year-on-year

    Cash from financing

    $4.90M
    VCYT annual cash flow from financing activities is $4.90 million

    Cash from financing 1-year change

    +72.86%
    VCYT annual cash flow from financing activities is up +72.86% year-on-year

    CAPEX

    CAPEX

    $11.29M
    VCYT annual capital expenditures is $11.29 million

    CAPEX 1-year change

    +13.31%
    VCYT annual capital expenditures is up +13.31% year-on-year

    Free Cash Flow

    Free cash flow

    $63.81M
    VCYT annual free cash flow is $63.81 million

    Free cash flow 1-year change

    +86.24%
    VCYT annual free cash flow is up +86.24% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    66.88%
    VCYT annual gross profit margin is 66.88%

    Operating margin

    4.38%
    VCYT annual operating profit margin is 4.38%

    Net margin

    5.42%
    VCYT annual net profit margin is 5.42%

    ROA & ROE

    ROA

    1.95%
    VCYT annual return on assets is 1.95%

    ROE

    2.17%
    VCYT annual return on equity is 2.17%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    93.39
    VCYT price to earnings ratio is 93.39

    PE ratio Sector rank

    90.57%
    VCYT price to earnings ratio is higher than 90.57% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.99
    VCYT price to book ratio is 1.99

    PB ratio Sector rank

    52.82%
    VCYT price to book ratio is higher than 52.82% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.06
    VCYT price to sales ratio is 5.06

    PS ratio Sector rank

    58.44%
    VCYT price to sales ratio is higher than 58.44% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.15B
    VCYT enterprise value is $2.15 billion

    Enterprise value Sector rank

    81.23%
    VCYT enterprise value is higher than 81.23% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    35.03
    VCYT EV/EBITDA is 35.03

    EV/EBITDA Sector rank

    94.81%
    VCYT EV/EBITDA is higher than 94.81% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.73
    VCYT annual current ratio is 4.73

    Quick ratio

    4.46
    VCYT annual quick ratio is 4.46

    Leverage

    Debt to equity

    0.00
    VCYT annual debt to equity ratio is 0.00

    Interest coverage ratio

    9755.00
    VCYT annual interest coverage ratio is 9755.00

    Risk & Stability

    Piotroski F-Score

    7
    VCYT piotroski f-score is 7

    Altman Z-Score

    9.39
    VCYT altman z-score is 9.39

    Analyst ratings

    Recent major analysts updates

    May 8, 25 UBS
    Buy
    May 8, 25 Needham
    Buy
    Apr 9, 25 Guggenheim
    Buy
    Mar 26, 25 Stephens & Co.
    Overweight
    Mar 20, 25 Craig-Hallum
    Buy
    Feb 25, 25 UBS
    Buy
    Feb 25, 25 Needham
    Buy
    Feb 25, 25 Guggenheim
    Buy
    Jan 29, 25 Needham
    Buy
    Dec 5, 24 Goldman Sachs
    Neutral

    Institutional Ownership

    Screeners with VCYT included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    • What is the ticker symbol for Veracyte, Inc.?
    • Does Veracyte, Inc. pay dividends?
    • What sector is Veracyte, Inc. in?
    • What industry is Veracyte, Inc. in?
    • What country is Veracyte, Inc. based in?
    • When did Veracyte, Inc. go public?
    • Is Veracyte, Inc. in the S&P 500?
    • Is Veracyte, Inc. in the NASDAQ 100?
    • Is Veracyte, Inc. in the Dow Jones?
    • When was Veracyte, Inc.'s last earnings report?
    • When does Veracyte, Inc. report earnings?

    What is the ticker symbol for Veracyte, Inc.?

    The ticker symbol for Veracyte, Inc. is NASDAQ:VCYT

    Does Veracyte, Inc. pay dividends?

    No, Veracyte, Inc. does not pay dividends

    What sector is Veracyte, Inc. in?

    Veracyte, Inc. is in the Healthcare sector

    What industry is Veracyte, Inc. in?

    Veracyte, Inc. is in the Diagnostics & Research industry

    What country is Veracyte, Inc. based in?

    Veracyte, Inc. is headquartered in United States

    When did Veracyte, Inc. go public?

    Veracyte, Inc.'s initial public offering (IPO) was on October 30, 2013

    Is Veracyte, Inc. in the S&P 500?

    No, Veracyte, Inc. is not included in the S&P 500 index

    Is Veracyte, Inc. in the NASDAQ 100?

    No, Veracyte, Inc. is not included in the NASDAQ 100 index

    Is Veracyte, Inc. in the Dow Jones?

    No, Veracyte, Inc. is not included in the Dow Jones index

    When was Veracyte, Inc.'s last earnings report?

    Veracyte, Inc.'s most recent earnings report was on August 6, 2025

    When does Veracyte, Inc. report earnings?

    The next expected earnings date for Veracyte, Inc. is November 5, 2025
    On this page